We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$993M
AUM Growth
+$129M
Cap. Flow
+$92.7M
Cap. Flow %
9.33%
Top 10 Hldgs %
30.04%
Holding
594
New
70
Increased
355
Reduced
101
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$5.38M
2
AAPL icon
Apple
AAPL
+$4.64M
3
JPM icon
JPMorgan Chase
JPM
+$4.48M
4
AMZN icon
Amazon
AMZN
+$3.83M
5
FSK icon
FS KKR Capital
FSK
+$3.18M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$4.92M
2
FSKR
FS KKR Capital Corp. II
FSKR
+$3.37M
3
TSLA icon
Tesla
TSLA
+$1.2M
4
NWSA icon
News Corp Class A
NWSA
+$944K
5
NIO icon
NIO
NIO
+$835K

Sector Composition

Rank Sector Weight
1 Technology 25.77%
2 Financials 14.14%
3 Healthcare 12.99%
4 Consumer Discretionary 12.37%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLCA
501
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$195K 0.02%
16,853
-200
-1% -$2.32K
ADN
502
DELISTED
Advent Technologies
ADN
$194K 0.02%
671
+36
+6% +$12K
ETRM
503
DELISTED
EnteroMedics Inc.
ETRM
$185K 0.02%
+37,067
New +$185K
HBAN icon
504
Huntington Bancshares
HBAN
$35.5B
$183K 0.02%
+12,851
New +$197K
TAK icon
505
Takeda Pharmaceutical
TAK
$55.7B
$183K 0.02%
10,844
-531
-5% -$9.04K
CGEN icon
506
Compugen
CGEN
$228M
$180K 0.02%
21,799
-10
-0% -$81
CIM
507
Chimera Investment
CIM
$1B
$180K 0.02%
3,980
+177
+5% +$7.36K
CRON
508
Cronos Group
CRON
$1.14B
$170K 0.02%
19,731
-375
-2% -$3.1K
SIRI icon
509
SiriusXM
SIRI
$10.1B
$157K 0.02%
2,406
-194
-7% -$12.2K
ZNGA
510
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$131K 0.01%
12,309
-4,208
-25% -$44.3K
ERIC icon
511
Ericsson
ERIC
$33.3B
$129K 0.01%
+10,285
New +$138K
LYG icon
512
Lloyds Banking Group
LYG
$91.3B
$121K 0.01%
47,416
-1,956
-4% -$5.02K
CCLD icon
513
CareCloud
CCLD
$112M
$118K 0.01%
13,975
-60
-0.4% -$498
SAN icon
514
Banco Santander
SAN
$210B
$103K 0.01%
26,373
-894
-3% -$3.47K
PRTK
515
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$100K 0.01%
14,679
-600
-4% -$4.85K
FEI
516
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$96K 0.01%
12,163
– –
MBAI
517
Check-Cap
MBAI
$10.9M
$82K 0.01%
3,200
– –
PRQR icon
518
ProQR Therapeutics
PRQR
$265M
$67K 0.01%
+10,000
New +$64.5K
BCLI
519
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$65K 0.01%
1,136
+67
+6% +$3.58K
CARM
520
DELISTED
Carisma Therapeutics
CARM
$56K 0.01%
+610
New +$38.9K
BBD icon
521
Banco Bradesco
BBD
$36.7B
$53K 0.01%
+11,427
New +$49.7K
IBIO icon
522
iBio
IBIO
$70M
$39K ﹤0.01%
52
– –
AMPE
523
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$38K ﹤0.01%
75
– –
SNDL icon
524
Sundial Growers
SNDL
$320M
$36K ﹤0.01%
3,804
+2,164
+132% +$19.8K
APTX
525
DELISTED
Aptinyx Inc. Common Stock
APTX
$33K ﹤0.01%
11,791
– –
19 20
21
22 23

Similar funds

AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
YC
Yarbrough Capital Franklin, Tennessee $2.85B AUM 36.22% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return

HighPoint Advisor Group's Q2 2021 Portfolio in Review

As of Q2 2021, HighPoint Advisor Group held 594 positions worth $993M, up 15% from $864M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

HighPoint Advisor Group deployed $92.7M of net new capital in Q2 2021, opening 70 new positions and adding to 355 existing holdings. Its largest new stake was NRX Pharmaceuticals: 4,350 shares worth $505K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sherwin-Williams, an estimated $4.92M trimmed.

  • HighPoint Advisor Group's largest Q2 2021 buy was NRX Pharmaceuticals: 4,350 shares worth $505K.
  • HighPoint Advisor Group added most to Microsoft in Q2 2021, an estimated $5.38M increase.
  • HighPoint Advisor Group's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $4.92M.
  • HighPoint Advisor Group fully exited FS KKR Capital Corp. II in Q2 2021, selling an estimated $3.37M.
  • HighPoint Advisor Group's ten largest holdings make up 30% of its $993M portfolio in Q2 2021.
  • HighPoint Advisor Group opened 70 new positions and closed 33 in Q2 2021.
  • HighPoint Advisor Group's portfolio value rose 15% quarter-over-quarter to $993M.

Based on HighPoint Advisor Group's 13F filing for Q2 2021, filed 29 Jul 2021.